Skip to main content

Xanne Hoyt-Miggelbrink

Postdoctoral Associate
Integrative Immunobiology

Overview


Program Start Year:  2017
Fecci Lab

Current Appointments & Affiliations


Recent Publications


CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.

Journal Article Nat Cancer · September 2023 The accepted paradigm for both cellular and anti-tumor immunity relies upon tumor cell killing by CD8+ T cells recognizing cognate antigens presented in the context of target cell major histocompatibility complex (MHC) class I (MHC-I) molecules. Likewise, ... Full text Link to item Cite
View All Publications

Recent Grants


Nervous system control and regulation of the immune system following neurological insults

ResearchPostdoctoral Associate · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2026

Removing Barriers to Immunotherapy Against Tumors Within the Intracranial Compartment

ResearchGraduate Student · Awarded by Cancer Research Institute · 2021 - 2026

Development of BARR2 Small Molecule Inhibitors for Brain Cancer Therapy

ResearchGraduate Student · Awarded by Charlie Teo Foundation · 2021 - 2023

View All Grants

External Links


ORCID